nqo

4-Nitroquinoline 1-oxide (4-NQO) is a chemical carcinogen that induces mutations in bacteria, fungi, and animals through the formation of large amounts of purine adducts.

HTS07545 is a potent sulfide:quinone oxidoreductase inhibitor (IC50: 30 nM) that reduces the rate of hydrogen sulfide (H2S) decomposition and has been used in heart failure studies.

NQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.

NQO2-IN-1, a resveratrol analog, is a potent quinone oxidoreductase 2 (NQO2) inhibitor (IC50=95 nM) with antitumor potential through the generation of ROS and up-regulation of DR5 (death receptor 5) to reverse trial resistance and promote apoptosis.

ICy-Q, a near-infrared (NIR) reagent activated by quinone oxidoreductase 1 (NQO-1), interacts with NQO-1 to yield the reduced product ICy-OH. This derivative selectively triggers pyroptosis and resultant death in pancreatic cancer cells. Moreover, ICy-Q serves as a valuable instrument for the expedited and precise diagnosis of intraoperative pathological sections [1].